Deferred Tax Assets, Operating Loss Carryforwards in USD of Praxis Precision Medicines, Inc. from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Praxis Precision Medicines, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and change rate from Q4 2019 to Q4 2024.
  • Praxis Precision Medicines, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 31 Dec 2024 was $90.1M, a 20.9% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Praxis Precision Medicines, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $90.1M +$15.6M +20.9% 31 Dec 2024 10-K 28 Feb 2025
Q4 2023 $74.5M +$14.5M +24.1% 31 Dec 2023 10-K 28 Feb 2025
Q4 2022 $60M +$3.57M +6.31% 31 Dec 2022 10-K 05 Mar 2024
Q4 2021 $56.5M +$30M +114% 31 Dec 2021 10-K 07 Feb 2023
Q4 2020 $26.4M +$11.9M +82.3% 31 Dec 2020 10-K 28 Feb 2022
Q4 2019 $14.5M 31 Dec 2019 10-K 17 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.